United Kingdom· GB-APID-20358611000001109
Caprelsa 100mg tablets
A vandetanib product containing vandetanib, registered in United Kingdom by Sanofi. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Vandetanib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EX04 (vandetanib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Vandetanib · ATC L01EX04
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vandetanib costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vandetanib · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$239.02
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Vandetanib
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- L01EX04
- ATC class
- Vandetanib
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5000455019782
- gtin5000283660774
- gtin5000283662167
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
351 interactions on record for vandetanib.
Graded by severity as the source publishes them — 244 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vandetanib · interactions on record
351 records
- 244 severe
- 95 moderate
- 12 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vandetanib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaCAPRELSASANOFI-AVENTIS CANADA INC
- SwitzerlandCaprelsa
- FinlandCaprelsaEsteve Pharmaceuticals S.A.S.
- NorwayCaprelsaEsteve Pharmaceuticals S.A
- CzechiaCAPRELSAEsteve Pharmaceuticals S.A., Barcelona
- SpainCAPRELSA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAEsteve Pharmaceuticals S.A.
- FranceCAPRELSA 100 mg, comprimé pelliculéESTEVE PHARMACEUTICALS (ESPAGNE)
- IrelandCaprelsa 100 mg film-coated tabletsEsteve Pharmaceuticals S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Caprelsa
- Liechtenstein · Caprelsa
- Norway · Caprelsa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b20b5bf5-fdec-458e-9595-e68888a7e9ad GET /v1/drugs/b20b5bf5-fdec-458e-9595-e68888a7e9ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "20358611000001109",
"desc": "Caprelsa 100mg tablets (Sanofi)",
"form": "Oral tablet",
"vpid": "20363411000001107",
"source": "dmd",
"vtm_id": "777915001",
"strength": "100 mg",
"substance": "Vandetanib",
"ingredient": "Vandetanib",
"supplier_code": "9190711000001101"
}See everything about vandetanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.